ascopubs.org/doi/10.1200/JCO.2024.42.3_suppl.157

Yu Aoki et al. Clinical utility of upfront circulating tumor DNA (ctDNA) genotyping to guide first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC): A GOZILA substudy. 2024ASCO-GI  2024/1/20
https://ascopubs.org/doi/10.1200/JCO.2024.42.3_suppl.157